Xcout Intel
Sentrimed, Inc.
Sentrimed, Inc. is a clinical-stage biopharmaceutical company creating safer therapies that has secured federal government contracts and operates with registered locations including Washington, DC.
Subscribe to see Sentrimed, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sentrimed, Inc. at a glance
Sentrimed, Inc. is a company headquartered in United States. It has raised at least $750,000 across the 2 funding rounds on record. Its most recent funding round raised $250,000 in May 2026. Xcout tracks 12 named people at Sentrimed, Inc., including William Ragatz (Chairman and President and CEO).
Sentrimed, Inc. leadership
- William RagatzChairman and President and CEO
- Dr. Jack Goldberg, MDChief Medical Officer
- Christopher LeonardSecretary
- Mari Rhodehamel YinTreasurer
- Arye RosenExecutive Officer
- Christopher LeonardExecutive Officer
6 more named people on record for Sentrimed, Inc., with roles, board committees and tenure — see the full roster →
Sentrimed, Inc. funding rounds
At least $750,000 raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $250,000 | — | |
| SEC Form D filing | $500,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Sentrimed, Inc. competitors
A few of Sentrimed, Inc.'s closest competitors — see the full list of competitors and alternatives →
Chase Therapeutics Corp. is a biopharmaceutical holding company headquartered in Washington, District of Columbia, focusing on drug pipelines, patents, and clinical trials. The company develops therapeutic products aimed at serving both patients and medical markets.
Sensible Biotechnologies, Inc. is an active biotechnology company with operational locations in the United States and Oxfordshire, focusing on advanced molecular innovations. The company is registered with a corporate trust center address in Wilmington, Delaware.
PharmD Live Corp maintains its corporate office in Washington, D.C., operating in the healthcare and clinical technology sector.
The Biomedical Advanced Research and Development Authority (BARDA) is a government administration agency based in Washington, D.C. focused on developing medical countermeasures for public health.
Sentien Biotechnologies, Inc. is a clinical-stage biotechnology company pursuing novel cell-therapy approaches with specialized technologies. The for-profit company focuses on developing advanced therapeutic products to address critical medical needs.
Get Sentrimed, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Sentrimed, Inc. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access